Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.57 USD | -1.24% | -3.04% | -26.83% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Its low valuation, with P/E ratio at 9.29 and 6.02 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Multiline Insurance & Brokers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-26.83% | 471M | C+ | ||
+9.28% | 110B | B- | ||
+6.33% | 99.27B | B | ||
-0.30% | 69.78B | C+ | ||
+23.28% | 29.46B | A- | ||
+9.28% | 19.28B | A- | ||
-4.93% | 12.24B | B- | ||
+8.40% | 10.92B | A- | ||
+9.25% | 10.46B | A | ||
+19.19% | 10.09B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CRD.B Stock
- Ratings Crawford & Company